Mateon’s Global Study for Artemisinin Intervention Against COVID-19 Cleared for Patient Enrollment in India

NEXT STORY
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
PREV STORY
SpringWorks Therapeutics Announces Clinical Collaboration with Janssen to Evaluate Nirogacestat in Combination with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma to Host First Quarter 2018 Financial Results Conference Call on May 8, 2018

author_avatar
NASDAQ Market News

GeoVax Reports 2019 Year-End Financial Results And Provides Corporate Update

author_avatar
NASDAQ Market News

Incyte and Calithera Biosciences Announce Global Collaboration to Develop and Commercialize CB-1158, a First-in-class, Small Molecule Arginase Inhibitor

Incyte gains worldwide rights to CB-1158 for hematology and oncology indications Calithera to receive a ...

author_avatar
NASDAQ Market News